Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.
NaPi2b, a sodium-dependent phosphate transporter, is highly expressed in ovarian carcinomas and is recognized by the murine monoclonal antibody MX35. The antibody had shown excellent targeting to ovarian cancer in several early phase clinical trials but being murine the antibody's full therapeu...
Guardado en:
Autores principales: | Mariana Lopes dos Santos, Fernanda Perez Yeda, Lilian Rumi Tsuruta, Bruno Brasil Horta, Alécio A Pimenta, Theri Leica Degaki, Ibere C Soares, Maria Carolina Tuma, Oswaldo Keith Okamoto, Venancio A F Alves, Lloyd J Old, Gerd Ritter, Ana Maria Moro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d963669f4fe0458ea7459834bd3e8964 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
por: Nayanendu Saha, et al.
Publicado: (2022) -
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
por: Matthaiou EI, et al.
Publicado: (2014) -
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
por: George P Kim, et al.
Publicado: (2008) -
Complexes of DNA with fluorescent dyes are effective reagents for detection of autoimmune antibodies
por: Ivana Domljanovic, et al.
Publicado: (2017) -
The Road to Toxin-Targeted Therapeutic Antibodies
por: Thomas R. Kozel
Publicado: (2014)